Back

Mid-term outcomes in heart failure patients treated with non-vitamin K antagonist oral anticoagulants. A real world study.

28 May 2018 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Atrial Fibrillation - Epidemiology, Prognosis, Outcome Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2018

About the speaker

Photo
Doctor Cristina Goena Vives

Donostia University Hospital, Donostia (Spain)

4 More presentations in this session

Presentation thumbnail
Professor G. Giannakoulas (Thessaloniki, GR)
Abstract Slides
Presentation thumbnail
Professor L. Jesel (Strasbourg, FR)
Abstract Slides
Presentation thumbnail
Doctor H. Nascimento (Santa Maria da Feira, PT)
Abstract
Presentation thumbnail
Doctor P. Marques (Lisbon, PT)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 3 - Atrial Fibrillation - Epidemiology, Prognosis, Outcome

The Event

Event poster

Heart Failure 2018

28 May 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Anticoagulation with direct-acting anticoagulants decreases the risk of cardiovascular adverse events in patients with heart failure and atrial fibrillation compared to acenocoumarol
29 June 2021
thumbnail
Congress Presentation
Guideline-directed medication therapy use among patients with HFrEF receiving vericiguat: comparing findings from a real-world study to clinical trials
29 August 2025
thumbnail
Congress Presentation
Use of Non-vitamin K antagonist Oral Anticoagulants in a real-world setting: a community pharmacy-based study.
31 August 2019
thumbnail
Congress Presentation
Pharmacologic transition in the care of patients with heart failure with reduced ejection fraction - a real life analysis
20 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources